Source link : https://newshealth.biz/health-news/novel-drug-lowers-stubbornly-high-bp-in-phase-3-trial/
TOPLINE: Lorundrostat, a novel aldosterone synthase inhibitor, lowered blood pressure among adults with uncontrolled hypertension in a phase 3 trial, including in treatment-resistant cases. Adverse events tended to be mild and resolved without intervention, the investigators reported. METHODOLOGY: Launch-HTN enrolled 1083 participants across 159 clinic sites in 13 countries between November 2023 and September 2024, […]
The post Novel Drug Lowers Stubbornly High BP in Phase 3 Trial first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-30 15:05:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8